Details of the Drug

General Information of Drug (ID: DMFQXIP)

• Drug Name: AZD9150

Indication

Disease Entry	ICD 11	Status	REF
Haematological malignancy	2B33.Y	Phase 1/2	[1]

• Cross-matching ID: TTD ID: D07RZW

References

• [1] Clinical pipeline report, company report or official report of ISIS Pharmaceuticals.